Medical Journals

Characterization of an Immunodominant Antigenic Site on Gb Virus C Glycoprotein E2 That is Involved in Cell Binding.

Authors:
  • McLinden James H
  • Kaufman Thomas M
  • Xiang Jinhua
  • Chang Qing
  • Klinzman Donna
  • Engel Alfred M
  • Hess Georg
  • Schmidt Urban
  • Houghton Michael
  • Stapleton Jack T

From: Department of Internal Medicine, SW54, GH, The University of Iowa, Iowa City, IA 52242, USA.

Journal of virology

  • Publish Date: Dec 2006
  • ISSN: 0022-538X
  • Volume: 80
  • Issue: 24
  • Pages: 12131-40
  • Medium: Print
  • Language: English
  • Citation (JAMA): McLinden James H, Kaufman Thomas M, Xiang Jinhua, et al. Characterization of an Immunodominant Antigenic Site on Gb Virus C Glycoprotein E2 That is Involved in Cell Binding.. J. Virol. Dec 2006;80:12131-40

Abstract

GB virus type C (GBV-C) is a human flavivirus that may cause persistent infection, although most infected individuals clear viremia and develop antibodies to the envelope glycoprotein E2. To study GBV-C E2 antigenicity and cell binding, murine anti-E2 monoclonal antibodies (MAbs) were evaluated to topologically map immunogenic sites on GBV-C E2 and for the ability to detect or block recombinant E2 binding to various cell lines. Five competition groups of MAbs were identified. Groups I and II did not compete with each other. Group III competed with both groups I and II. Group IV did not compete with group I, II, or III. One MAb competed with all of the other MAbs, suggesting that the epitopes bound by these MAbs are intimately related. Individually, none of the MAbs competed extensively with polyclonal human convalescent antibody (PcAb); however, combinations of all five MAb groups completely blocked PcAb binding to E2, suggesting that the epitopes bound by these MAbs form a single, immunodominant antigenic site. Only group I and III MAbs detected purified recombinant E2 bound to cells in binding assays. In contrast, group II MAbs neutralized the binding of E2 to cells. Both PcAb and MAbs were conformation dependent, with the exception of one group II MAb (M6). M6 bound to a five-amino-acid sequence on E2 if the peptide included four C-terminal or eight N-terminal residues, suggesting that the GBV-C E2 protein contains a single immunodominant antigenic site which includes a complex epitope that is involved in specific cellular binding.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Viral, Cell Line, Epitope Mapping, GB virus C, Humans, Immunodominant Epitopes, Mice, Molecular Sequence Data, Viral Envelope Proteins, Virus Attachment


Check for Full Text / PubMed Unique Identifier (PMID): 17035329


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.